Di Fei Sun

427 citations
17 papers · 342 indexed · h-index 11
Topics
Growth Hormone and Insulin-like Growth Factors (4 papers)Acute Kidney Injury Research (4 papers)Chronic Kidney Disease and Diabetes (3 papers)
Partner nations
JapanUnited StatesChina

In The Last Decade

Di Fei Sun

17 papers receiving 339 citations

Peers

Di Fei Sun
Comparison fields: 5 of 74
  • Nephrology 106
  • Molecular Biology 91
  • Endocrinology, Diabetes and Metabolism 78
  • Surgery 47
  • Genetics 46
Replace Fuye Yang with:
Fuye Yang China
Warangkana Pichaiwong Thailand
Przemyslaw Hirszel United States
Afef Bahlous Tunisia
Patrick Wilkinson United States
Anna Rita Plati United States
Josefin Axelsson Sweden
Stella McGinn Australia
Amjad Shidyak United States
Sandeep Vetteth United States
Di Fei Sun relative to Fuye Yang China Fuye Yang's profile →
Citations per field
00.5×1.5×2.4×
Fuye Yang · 1×
Citations per year

Countries citing papers authored by Di Fei Sun

Since Specialization
Citations

This map shows the geographic impact of Di Fei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Fei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Fei Sun more than expected).

Fields of papers citing papers by Di Fei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Fei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Fei Sun. The network helps show where Di Fei Sun may publish in the future.

Co-authorship network of co-authors of Di Fei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Di Fei Sun. A scholar is included among the top collaborators of Di Fei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Fei Sun. Di Fei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 12
3 25
4 2
5 7
6 64
7 10
8 53
9 13
10 5
11 5
12 33
13 17
14 25
15 14
16 48
17 6

About Di Fei Sun

Di Fei Sun is a scholar working on Nephrology, Urology and Immunology and Allergy, having authored 17 papers that have together received 342 indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (4 papers), Acute Kidney Injury Research (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). The work is most often cited by research in Nephrology (106 citations), Endocrinology, Diabetes and Metabolism (78 citations) and Transplantation (9 citations). Di Fei Sun has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Akira Hishida, Yoshihide Fujigaki, Ralph Rabkin, Katsuhiko Yonemura, T. Fujimoto, Franz Schaefer, Yu Chen, Jane C. Tan, Zhilan Zheng and Padmaja Tummala. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026